Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Marc Elia Appointed Chief Executive Officer of Invivyd, Inc.
PUBLIC · IVVDSep 01, 2026•5 days ago
Position
Independent Director
Company
Invivyd
Ajay Royan
WalthamBiotechnology
Description
On August 30, 2026, Invivyd, Inc. appointed Marc Elia as its new Chief Executive Officer. This decision was made by the Board of Directors, effective immediately
Company Information
Company
Invivyd
Location
1601 Trapelo Road
Waltham, Massachusetts, United States
About
Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
Don't miss Invivyd's next move
Get an email the moment Invivyd changes its leadership, hires an exec, or expands, usually minutes after it happens.
WalthamBiotechnology